National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 322225

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

VAERS ID: 322225
VAERS Form:
Age:0.2
Gender:Female
Location:Foreign
Vaccinated:2008-01-18
Onset:2008-01-21
Submitted:2008-08-14
Entered:2008-08-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
HEP: HEP B (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
HIBV: HIB (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
IPV: POLIO VIRUS, INACT. (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
PPV: PNEUMO (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Dehydration, Faeces discoloured, Inappropriate schedule of drug administration, Intestinal ischaemia, Intussusception, Laparotomy, Surgery, Vomiting, Food intolerance

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0532063A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). The subject had no history of family history of intussusception or bowel abnormalities. She had no congenital intestinal malformation or other gastrointestinal malformation and dysfunction. Previous and/or concurrent vaccination included DTaP-IPV-HIB (manufacturer unspecified; intramuscular) given on 18 January 2008; hepatitis B vaccine recombinant (manufacturer unspecified; intramuscular) given on 4 November 2007 and 18 January 2008; pneumococcal vaccine, unspecified (manufacturer unspecified; intramuscular) given on 18 January 2008; tuberculosis vaccine (manufacturer unspecified; intradermal) given on 4 November 2007. On 18 January 2008, the subject received the 1st dose of ROTARIX (oral, lot number not provided). On 21 January 2008, 3 days after vaccination with the 1st dose of ROTARIX, the subject experienced invagination of intestine. The subject started with alimentary vomiting and intolerance to PO with 30 hrs of evolution, she was treated with co-trimoxazole and metoclopramide. On 23 January 2008 at 13.00 hrs, the subject had diagnosis of moderate dehydration and was giving oral hydration. She came back for another consult on the same day at 15.35 hrs with stools that "seemed like black currant jelly"; hospitalization was required with the diagnosis of intestinal intussusception. Abdominal radiograph, abdominal ultrasound and abdominal CT were not performed. The physician considered the events were clinically significant (or requiring intervention). A close reduction surgery was performed on 23 January 2008 without complications by laparotomy finding ileo ileal and ileo colic invagination with data of intestinal ischemia that began to remit at the end of procedure. Intestinal resection was not required. On 23 January 2008, intestinal invagination resolved. The physician considered the events were possibly related to


Changed on 5/13/2013

VAERS ID: 322225 Before After
VAERS Form:
Age:0.2
Gender:Female
Location:Foreign
Vaccinated:2008-01-18
Onset:2008-01-21
Submitted:2008-08-14
Entered:2008-08-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
HEP: HEP B (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
HIBV: HIB (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
IPV: POLIO VIRUS, INACT. (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
PPV: PNEUMO (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 0 - / PO
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Dehydration, Faeces discoloured, Inappropriate schedule of drug administration, Intestinal ischaemia, Intussusception, Laparotomy, Surgery, Vomiting, Food intolerance

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0532063A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). The subject had no history of family history of intussusception or bowel abnormalities. She had no congenital intestinal malformation or other gastrointestinal malformation and dysfunction. Previous and/or concurrent vaccination included DTaP-IPV-HIB (manufacturer unspecified; intramuscular) given on 18 January 2008; hepatitis B vaccine recombinant (manufacturer unspecified; intramuscular) given on 4 November 2007 and 18 January 2008; pneumococcal vaccine, unspecified (manufacturer unspecified; intramuscular) given on 18 January 2008; tuberculosis vaccine (manufacturer unspecified; intradermal) given on 4 November 2007. On 18 January 2008, the subject received the 1st dose of ROTARIX (oral, lot number not provided). On 21 January 2008, 3 days after vaccination with the 1st dose of ROTARIX, the subject experienced invagination of intestine. The subject started with alimentary vomiting and intolerance to PO with 30 hrs of evolution, she was treated with co-trimoxazole and metoclopramide. On 23 January 2008 at 13.00 hrs, the subject had diagnosis of moderate dehydration and was giving oral hydration. She came back for another consult on the same day at 15.35 hrs with stools that "seemed like black currant jelly"; hospitalization was required with the diagnosis of intestinal intussusception. Abdominal radiograph, abdominal ultrasound and abdominal CT were not performed. The physician considered the events were clinically significant (or requiring intervention). A close reduction surgery was performed on 23 January 2008 without complications by laparotomy finding ileo ileal and ileo colic invagination with data of intestinal ischemia that began to remit at the end of procedure. Intestinal resection was not required. On 23 January 2008, intestinal invagination resolved. The physician considered the events were possibly related to


Changed on 4/14/2017

VAERS ID: 322225 Before After
VAERS Form:
Age:0.2
Gender:Female
Location:Foreign
Vaccinated:2008-01-18
Onset:2008-01-21
Submitted:2008-08-14
Entered:2008-08-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
HEP: HEP B (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
HIBV: HIB (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
IPV: POLIO VIRUS, INACT. (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
PPV: PNEUMO (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Dehydration, Faeces discoloured, Inappropriate schedule of drug administration, Intestinal ischaemia, Intussusception, Laparotomy, Surgery, Vomiting, Food intolerance

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0532063A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). The subject had no history of family history of intussusception or bowel abnormalities. She had no congenital intestinal malformation or other gastrointestinal malformation and dysfunction. Previous and/or concurrent vaccination included DTaP-IPV-HIB (manufacturer unspecified; intramuscular) given on 18 January 2008; hepatitis B vaccine recombinant (manufacturer unspecified; intramuscular) given on 4 November 2007 and 18 January 2008; pneumococcal vaccine, unspecified (manufacturer unspecified; intramuscular) given on 18 January 2008; tuberculosis vaccine (manufacturer unspecified; intradermal) given on 4 November 2007. On 18 January 2008, the subject received the 1st dose of ROTARIX (oral, lot number not provided). On 21 January 2008, 3 days after vaccination with the 1st dose of ROTARIX, the subject experienced invagination of intestine. The subject started with alimentary vomiting and intolerance to PO with 30 hrs of evolution, she was treated with co-trimoxazole and metoclopramide. On 23 January 2008 at 13.00 hrs, the subject had diagnosis of moderate dehydration and was giving oral hydration. She came back for another consult on the same day at 15.35 hrs with stools that "seemed like black currant jelly"; hospitalization was required with the diagnosis of intestinal intussusception. Abdominal radiograph, abdominal ultrasound and abdominal CT were not performed. The physician considered the events were clinically significant (or requiring intervention). A close reduction surgery was performed on 23 January 2008 without complications by laparotomy finding ileo ileal and ileo colic invagination with data of intestinal ischemia that began to remit at the end of procedure. Intestinal resection was not required. On 23 January 2008, intestinal invagination resolved. The physician considered the events were possibly related to vaccination with ROTARIX. Physician didn''t have a favorable progress note or a surgery note after this data. No more information available.


Changed on 9/14/2017

VAERS ID: 322225 Before After
VAERS Form:(blank) 1
Age:0.2
Gender:Female
Location:Foreign
Vaccinated:2008-01-18
Onset:2008-01-21
Submitted:2008-08-14
Entered:2008-08-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UNK UN / IM
HEP: HEP B (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UNK UN / IM
HIBV: HIB (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UNK UN / IM
IPV: POLIO VIRUS, INACT. (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UNK UN / IM
PPV: PNEUMO (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UNK UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 0 1 - MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Dehydration, Faeces discoloured, Inappropriate schedule of drug administration, Intestinal ischaemia, Intussusception, Laparotomy, Surgery, Vomiting, Food intolerance

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0532063A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). The subject had no history of family history of intussusception or bowel abnormalities. She had no congenital intestinal malformation or other gastrointestinal malformation and dysfunction. Previous and/or concurrent vaccination included DTaP-IPV-HIB (manufacturer unspecified; intramuscular) given on 18 January 2008; hepatitis B vaccine recombinant (manufacturer unspecified; intramuscular) given on 4 November 2007 and 18 January 2008; pneumococcal vaccine, unspecified (manufacturer unspecified; intramuscular) given on 18 January 2008; tuberculosis vaccine (manufacturer unspecified; intradermal) given on 4 November 2007. On 18 January 2008, the subject received the 1st dose of ROTARIX (oral, lot number not provided). On 21 January 2008, 3 days after vaccination with the 1st dose of ROTARIX, the subject experienced invagination of intestine. The subject started with alimentary vomiting and intolerance to PO with 30 hrs of evolution, she was treated with co-trimoxazole and metoclopramide. On 23 January 2008 at 13.00 hrs, the subject had diagnosis of moderate dehydration and was giving oral hydration. She came back for another consult on the same day at 15.35 hrs with stools that "seemed like black currant jelly"; hospitalization was required with the diagnosis of intestinal intussusception. Abdominal radiograph, abdominal ultrasound and abdominal CT were not performed. The physician considered the events were clinically significant (or requiring intervention). A close reduction surgery was performed on 23 January 2008 without complications by laparotomy finding ileo ileal and ileo colic invagination with data of intestinal ischemia that began to remit at the end of procedure. Intestinal resection was not required. On 23 January 2008, intestinal invagination resolved. The physician considered the events were possibly related to vaccination with ROTARIX. Physician didn''t have a favorable progress note or a surgery note after this data. No more information available.


Changed on 2/14/2018

VAERS ID: 322225 Before After
VAERS Form:1
Age:0.2
Gender:Female
Location:Foreign
Vaccinated:2008-01-18
Onset:2008-01-21
Submitted:2008-08-14
Entered:2008-08-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK UN / IM
HEP: HEP B (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK UN / IM
HIBV: HIB (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK UN / IM
IPV: POLIO VIRUS, INACT. (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK UN / IM
PPV: PNEUMO (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Dehydration, Faeces discoloured, Inappropriate schedule of drug administration, Intestinal ischaemia, Intussusception, Laparotomy, Surgery, Vomiting, Food intolerance

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0532063A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). The subject had no history of family history of intussusception or bowel abnormalities. She had no congenital intestinal malformation or other gastrointestinal malformation and dysfunction. Previous and/or concurrent vaccination included DTaP-IPV-HIB (manufacturer unspecified; intramuscular) given on 18 January 2008; hepatitis B vaccine recombinant (manufacturer unspecified; intramuscular) given on 4 November 2007 and 18 January 2008; pneumococcal vaccine, unspecified (manufacturer unspecified; intramuscular) given on 18 January 2008; tuberculosis vaccine (manufacturer unspecified; intradermal) given on 4 November 2007. On 18 January 2008, the subject received the 1st dose of ROTARIX (oral, lot number not provided). On 21 January 2008, 3 days after vaccination with the 1st dose of ROTARIX, the subject experienced invagination of intestine. The subject started with alimentary vomiting and intolerance to PO with 30 hrs of evolution, she was treated with co-trimoxazole and metoclopramide. On 23 January 2008 at 13.00 hrs, the subject had diagnosis of moderate dehydration and was giving oral hydration. She came back for another consult on the same day at 15.35 hrs with stools that "seemed like black currant jelly"; hospitalization was required with the diagnosis of intestinal intussusception. Abdominal radiograph, abdominal ultrasound and abdominal CT were not performed. The physician considered the events were clinically significant (or requiring intervention). A close reduction surgery was performed on 23 January 2008 without complications by laparotomy finding ileo ileal and ileo colic invagination with data of intestinal ischemia that began to remit at the end of procedure. Intestinal resection was not required. On 23 January 2008, intestinal invagination resolved. The physician considered the events were possibly related to vaccination with ROTARIX. Physician didn''t have a favorable progress note or a surgery note after this data. No more information available.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=322225&WAYBACKHISTORY=ON


Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166